ASX ANNOUNCEMENT Imugene avian influenza vaccine trial update 17 January 2007, Sydney, Australia: Imugene Limited (ASX:IMU) today confirmed the efficacy trials for its new avian influenza vaccine candidates for poultry had progressed to the challenge phase. Since our most recent update, the chickens, other than the control group, have been successfully vaccinated in accordance with the trial protocol. =========================================
suc·cess·ful
Having a favorable outcome: Having obtained something desired or intended: was successful in stopping the leak of oil. Having achieved wealth or eminence:
vac·ci·nate
To inoculate with a vaccine in order to produce immunity to an infectious disease.
IMU Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)